Washout periods are an essential part of many clinical trials, with around 50% of studies including this phase to ensure more accurate observations of a new drug or intervention.
In some trials, such as randomized crossover trials, this period is even more common. In fact, 69% of randomized crossover trials include a washout period, making it an essential step in evaluating the effects and comparative effectiveness of different treatments.
Interested in participating in a clinical trial?
Connect to clinical trials that match your needs and gain access to cutting-edge treatments. Start your search today and discover the benefits of joining a trial!
What is a washout period?
A washout period is the time during which clinical trial participants take a break from receiving medical interventions. This commonly applies to people who are testing more than one drug during a trial. It can also occur before the trial begins to ensure that prior treatments do not influence the results.
The washout period aims to rule out any residual treatment effects, allowing the impacts of the new medication to be assessed accurately.
How long is a washout period?
Researchers will calculate the washout period based on the pharmacodynamics (how the drug affects the body) and the pharmacokinetics (how the body absorbs, distributes, metabolizes, and excretes the drug) of the drugs being studied.
In general, the washout period can last between two to six weeks – although this can be longer if controlled release medications are being studied.
Why is a washout period important?
If any previous medication remains in a participant’s system, it can interact with the new treatment and impact how it behaves – delivering inaccurate, or even harmful results. The body may also still be responding to the effects of the first treatment, which can affect the outcome of the trial.
By allowing time for any residual effects to be eliminated, the new drug can be tested in isolation and researchers can make accurate observations. This also lowers the risk of any negative drug interactions.
Why do some clinical trials need a washout period?
A washout period is generally needed when the same participant is entering a new phase of a trial, or an intervention is being tested on the same individual. This is especially important in trials which involve participants being given multiple treatments, where the washout period minimizes any carryover effects to ensure the results accurately reflect the current intervention.
How is a washout period different from a run-in period?
A run-in period is a phase at the start of a clinical trial where participants may receive a placebo, standard treatment, or no treatment to stabilize their condition and ensure they meet the trial's criteria.
In contrast, a washout period can occur either before or during the trial. It allows participants to stop taking previous treatments to eliminate any lingering effects, ensuring accurate results when a new intervention is introduced.
While the run-in period prepares participants for the trial, the washout period helps prevent interference from prior treatments.
What types of clinical trials use washout periods?
Various clinical trials include a washout period to ensure the study undertaken is accurate and improve participant safety. Clinical trials that typically use washout periods include crossover trials, cancer trials, and trials involving blood pressure medications.
Each of these trial types benefits from a washout period in unique ways to maintain the integrity of the study's findings.
Crossover trials
Crossover clinical trials assess the impacts of multiple interventions on the same patient. Two or more treatments are given to participants in different orders, and the results are compared to assess which is the most effective.
Washout periods are important during trials of multiple treatments as each new intervention can then be assessed in its own right.
Cancer trials
If a cancer treatment is being tested, a washout period will commonly be used after treatments such as chemotherapy and radiation, or even surgery. This helps ensure that the new treatment isn’t influenced by the residual effects of the previous one, and accurate conclusions can be drawn.
Trials with blood pressure medications
Researchers conducting blood pressure trials must ensure patients no longer have any existing medication in their system. This helps them gather accurate data, and assess whether the experimental treatment is more effective than the existing treatment.
Conclusion
Washout periods play a vital role in ensuring the integrity and accuracy of many types of clinical trials. By providing a break from previous treatments, these periods eliminate any lingering effects that could skew results, allowing researchers to assess new interventions with greater precision. Whether in crossover trials, cancer trials, or blood pressure medication studies, washout periods help maintain the validity of findings and protect participant safety.
Ultimately, this crucial phase helps ensure that clinical trials provide reliable, meaningful data, which is essential for advancing medical research and improving patient outcomes.
FAQs
What happens if a participant doesn't complete a washout period?
If a patient does not complete the washout period as stated in the study protocol, they won’t be allowed to move to the next phase of the clinical trial and will be excluded from the study.
How do researchers determine washout periods?
Researchers determine the right length for a washout period by considering factors like how the drug behaves in the body (pharmacokinetics), how it affects the body (pharmacodynamics), the condition being treated, and the risk of any remaining effects from the previous treatment interfering with the new one.